TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 61 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,912,186 | -40.8% | 103,744 | 0.0% | 0.50% | -40.2% |
| Q2 2023 | $6,613,100 | +156.7% | 103,744 | -2.0% | 0.84% | +128.9% |
| Q1 2023 | $2,575,828 | -16.3% | 105,914 | 0.0% | 0.37% | -9.6% |
| Q4 2022 | $3,075,743 | -41.5% | 105,914 | -39.7% | 0.41% | -73.4% |
| Q3 2022 | $5,262,000 | -16.1% | 175,520 | +1.2% | 1.52% | +27.0% |
| Q2 2022 | $6,274,000 | -10.9% | 173,520 | +6.6% | 1.20% | -10.6% |
| Q1 2022 | $7,039,000 | -11.8% | 162,703 | +2.2% | 1.34% | +77.5% |
| Q4 2021 | $7,978,000 | +25.4% | 159,203 | +59.2% | 0.76% | -76.1% |
| Q3 2021 | $6,363,000 | -11.6% | 100,000 | 0.0% | 3.16% | +22.3% |
| Q2 2021 | $7,196,000 | – | 100,000 | – | 2.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
| FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
| Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
| Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
| Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
| RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
| CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
| USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |